臨床試驗

Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer

NCT：NCT07781852 · NOT_YET_RECRUITING

NCT IDNCT07781852

狀態NOT_YET_RECRUITING

開始日期2026-09-01

完成時間2027-09-01

SponsorLumina Pharmaceuticals Inc (INDUSTRY)

First posted2026-08-24

Last updated2026-08-28

簡要摘要

The objective of this study is to assess two novel positron emission tomography (PET) radiotracers, \[64Cu\]CM500 and \[68Ga\]CM500, for Positron Emission Tomography-Magnetic Resonance Imaging (PET-MR) and Positron Emission Tomography / Computed Tomography (PET-CT) imaging of solid tumors. These tracers have the potential to detect solid tumors throughout the body and may enable doctors to identify smaller tumors than conventional imaging techniques.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。